Menu
×
John's Island Library
9 a.m. - 8 p.m.
Phone: (843) 559-1945
Main Library
9 a.m. - 8 p.m.
Phone: (843) 805-6930
West Ashley Library
9 a.m. - 7 p.m.
Phone: (843) 766-6635
Wando Mount Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 6 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 8 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 8 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. - 6 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 8 p.m.
Phone: (843) 744-2489
Hurd/St. Andrews Library
9 a.m. - 8 p.m.
Phone: (843) 766-2546
Folly Beach Library
9 a.m. - 5:30 p.m.
Phone: (843) 588-2001
Edisto Island Library
9 a.m. - 4 p.m.
Phone: (843) 869-2355
Dorchester Road Library
9 a.m. - 8 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 7 p.m.
Phone: (843) 722-7550
Baxter-Patrick James Island
9 a.m. - 8 p.m.
Phone: (843) 795-6679
Bees Ferry West Ashley Library
9 a.m. - 8 p.m.
Phone: (843) 805-6892
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Mobile Library
9 a.m. - 5 p.m.
Phone: (843) 805-6909
Today's Hours
John's Island Library
9 a.m. - 8 p.m.
Phone: (843) 559-1945
Main Library
9 a.m. - 8 p.m.
Phone: (843) 805-6930
West Ashley Library
9 a.m. - 7 p.m.
Phone: (843) 766-6635
Wando Mount Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 805-6888
Village Library
9 a.m. - 6 p.m.
Phone: (843) 884-9741
St. Paul's/Hollywood Library
9 a.m. - 8 p.m.
Phone: (843) 889-3300
Otranto Road Library
9 a.m. - 8 p.m.
Phone: (843) 572-4094
Mt. Pleasant Library
9 a.m. - 8 p.m.
Phone: (843) 849-6161
McClellanville Library
9 a.m. - 6 p.m.
Phone: (843) 887-3699
Keith Summey North Charleston Library
9 a.m. - 8 p.m.
Phone: (843) 744-2489
Hurd/St. Andrews Library
9 a.m. - 8 p.m.
Phone: (843) 766-2546
Folly Beach Library
9 a.m. - 5:30 p.m.
Phone: (843) 588-2001
Edisto Island Library
9 a.m. - 4 p.m.
Phone: (843) 869-2355
Dorchester Road Library
9 a.m. - 8 p.m.
Phone: (843) 552-6466
John L. Dart Library
9 a.m. - 7 p.m.
Phone: (843) 722-7550
Baxter-Patrick James Island
9 a.m. - 8 p.m.
Phone: (843) 795-6679
Bees Ferry West Ashley Library
9 a.m. - 8 p.m.
Phone: (843) 805-6892
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Mobile Library
9 a.m. - 5 p.m.
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Experimental Chemotherapy-Induced Mucositis: A Scoping Review Guiding the Design of Suitable Preclinical Models.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
- Author(s): Huang J;Huang J; Hwang AYM; Hwang AYM; Jia Y; Jia Y; Kim B; Kim B; Iskandar M; Iskandar M; Mohammed AI; Mohammed AI; Cirillo N; Cirillo N
- Source:
International journal of molecular sciences [Int J Mol Sci] 2022 Dec 06; Vol. 23 (23). Date of Electronic Publication: 2022 Dec 06.- Publication Type:
Systematic Review; Journal Article; Review- Language:
English - Source:
- Additional Information
- Source: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- Publication Information: Original Publication: Basel, Switzerland : MDPI, [2000-
- Subject Terms:
- Abstract: Mucositis is a common and most debilitating complication associated with the cytotoxicity of chemotherapy. The condition affects the entire alimentary canal from the mouth to the anus and has a significant clinical and economic impact. Although oral and intestinal mucositis can occur concurrently in the same individual, these conditions are often studied independently using organ-specific models that do not mimic human disease. Hence, the purpose of this scoping review was to provide a comprehensive yet systematic overview of the animal models that are utilised in the study of chemotherapy-induced mucositis. A search of PubMed/MEDLINE and Scopus databases was conducted to identify all relevant studies. Multiple phases of filtering were conducted, including deduplication, title/abstract screening, full-text screening, and data extraction. Studies were reported according to the updated Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines. An inter-rater reliability test was conducted using Cohen's Kappa score. After title, abstract, and full-text screening, 251 articles met the inclusion criteria. Seven articles investigated both chemotherapy-induced intestinal and oral mucositis, 198 articles investigated chemotherapy-induced intestinal mucositis, and 46 studies investigated chemotherapy-induced oral mucositis. Among a total of 205 articles on chemotherapy-induced intestinal mucositis, 103 utilised 5-fluorouracil, 34 irinotecan, 16 platinum-based drugs, 33 methotrexate, and 32 other chemotherapeutic agents. Thirteen articles reported the use of a combination of 5-fluorouracil, irinotecan, platinum-based drugs, or methotrexate to induce intestinal mucositis. Among a total of 53 articles on chemotherapy-induced oral mucositis, 50 utilised 5-fluorouracil, 2 irinotecan, 2 methotrexate, 1 topotecan and 1 with other chemotherapeutic drugs. Three articles used a combination of these drugs to induce oral mucositis. Various animal models such as mice, rats, hamsters, piglets, rabbits, and zebrafish were used. The chemotherapeutic agents were introduced at various dosages via three routes of administration. Animals were mainly mice and rats. Unlike intestinal mucositis, most oral mucositis models combined mechanical or chemical irritation with chemotherapy. In conclusion, this extensive assessment of the literature revealed that there was a large variation among studies that reproduce oral and intestinal mucositis in animals. To assist with the design of a suitable preclinical model of chemotherapy-induced alimentary tract mucositis, animal types, routes of administration, dosages, and types of drugs were reported in this study. Further research is required to define an optimal protocol that improves the translatability of findings to humans.
- References: J Immunol. 2015 Feb 15;194(4):1983-95. (PMID: 25589072)
Cancer Chemother Pharmacol. 2015 Mar;75(3):559-67. (PMID: 25572363)
Cancer Chemother Pharmacol. 2019 Jul;84(1):105-116. (PMID: 31069451)
Dig Dis Sci. 2013 Apr;58(4):959-69. (PMID: 23053903)
Eur J Pharm Sci. 2017 Aug 30;106:142-151. (PMID: 28546107)
Clin Oral Investig. 2014 Apr;18(3):1005-13. (PMID: 23949015)
Gut Microbes. 2022 Jan-Dec;14(1):2018898. (PMID: 35012435)
Cancer Chemother Pharmacol. 2011 Sep;68(3):713-20. (PMID: 21153821)
Cancer Chemother Pharmacol. 2007 Apr;59(5):603-12. (PMID: 16944152)
Int J Exp Pathol. 2011 Oct;92(5):357-65. (PMID: 21463374)
J Dig Dis. 2014 Aug;15(8):425-34. (PMID: 24814616)
Biomed Pharmacother. 2020 Apr;124:109829. (PMID: 31958765)
Acta Pharmacol Sin. 2020 Mar;41(3):348-357. (PMID: 31506573)
Rev Col Bras Cir. 2018 Oct 18;45(5):e1968. (PMID: 30379218)
Hum Exp Toxicol. 2016 Jan;35(1):10-20. (PMID: 25724421)
Int J Oral Maxillofac Surg. 2015 Jul;44(7):845-51. (PMID: 25662431)
J Oral Pathol Med. 2015 Jul;44(6):459-67. (PMID: 25213123)
Cancer Chemother Pharmacol. 2012 Apr;69(4):931-42. (PMID: 22101361)
Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G432-42. (PMID: 11841993)
J Oral Pathol Med. 2017 Oct;46(9):725-730. (PMID: 27977896)
Cancer Chemother Pharmacol. 2008 Feb;61(2):215-22. (PMID: 17426972)
Biomed Pharmacother. 2020 Aug;128:110262. (PMID: 32447214)
Mol Nutr Food Res. 2021 Sep;65(18):e2100222. (PMID: 34268870)
J Physiol Pharmacol. 2017 Feb;68(1):79-90. (PMID: 28456772)
Odontology. 2018 Oct;106(4):389-397. (PMID: 29797142)
Chemotherapy. 2007;53(5):344-55. (PMID: 17785971)
Biomolecules. 2020 Dec 29;11(1):. (PMID: 33383956)
Cancer Chemother Pharmacol. 2011 Jul;68(1):87-96. (PMID: 20844880)
Altern Ther Health Med. 2015;21 Suppl 2:22-31. (PMID: 26308757)
World J Gastroenterol. 2014 Apr 14;20(14):3751-61. (PMID: 24744571)
J Pharmacol Exp Ther. 2021 Nov;379(2):147-155. (PMID: 34400527)
Nanoscale. 2021 Jul 7;13(25):11250-11261. (PMID: 34152347)
Anticancer Drugs. 2015 Jan;26(1):35-45. (PMID: 24999837)
Braz Oral Res. 2017 Jul 03;31:e71. (PMID: 28678976)
Maturitas. 2017 Nov;105:100-106. (PMID: 28545905)
Cell Death Dis. 2016 May 19;7:e2229. (PMID: 27195676)
Anticancer Res. 2019 Jan;39(1):201-206. (PMID: 30591459)
Drug Deliv. 2022 Dec;29(1):1272-1281. (PMID: 35467472)
Pain. 2016 May;157(5):1004-1020. (PMID: 26808144)
Dig Dis Sci. 2013 Dec;58(12):3440-51. (PMID: 23695873)
Cell Death Dis. 2021 Oct 30;12(11):1034. (PMID: 34718327)
Immunology. 2022 Mar;165(3):355-368. (PMID: 34964126)
Gastroenterology. 2020 Dec;159(6):2146-2162.e33. (PMID: 32805281)
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Dec;116(6):702-8. (PMID: 24080533)
Int J Mol Sci. 2022 Apr 17;23(8):. (PMID: 35457248)
Biomed Pharmacother. 2011 Dec;65(8):547-54. (PMID: 21775092)
Toxicology. 2006 Jan 16;217(2-3):233-9. (PMID: 16278042)
Hum Exp Toxicol. 2016 Dec;35(12):1243-1251. (PMID: 26801985)
Cancer Chemother Pharmacol. 2011 May;67(5):1085-100. (PMID: 20661736)
Eur J Pharm Sci. 2018 Mar 30;115:158-166. (PMID: 29307857)
Inflammopharmacology. 2021 Oct;29(5):1539-1553. (PMID: 34420176)
Anticancer Drugs. 2022 Jan 1;33(1):11-18. (PMID: 34348356)
J Nutr. 2015 Jul;145(7):1472-80. (PMID: 26019247)
Cancer Chemother Pharmacol. 2002 Jul;50(1):53-8. (PMID: 12111112)
Exp Anim. 2016 Nov 1;65(4):329-336. (PMID: 27333839)
Cancer Biol Ther. 2006 Jan;5(1):34-8. (PMID: 16294027)
Int J Mol Sci. 2022 Apr 27;23(9):. (PMID: 35563254)
Phytomedicine. 2019 Feb 15;54:308-317. (PMID: 30396718)
PLoS One. 2018 Jun 4;13(6):e0198046. (PMID: 29864142)
J Pediatr Surg. 2021 Jul;56(7):1211-1218. (PMID: 33840504)
Cancer Chemother Pharmacol. 2022 Feb;89(2):275-281. (PMID: 34854953)
Bone Marrow Transplant. 2000 Jun;25(12):1269-78. (PMID: 10871732)
Sci Rep. 2020 Oct 1;10(1):16189. (PMID: 33004948)
Exp Biol Med (Maywood). 2010 Oct;235(10):1244-56. (PMID: 20682600)
Biol Pharm Bull. 2015;38(2):179-83. (PMID: 25747976)
Arch Oral Biol. 2021 Nov;131:105250. (PMID: 34482219)
Nutr Cancer. 2019;71(7):1142-1152. (PMID: 31210536)
J Ethnopharmacol. 2016 Aug 22;190:200-11. (PMID: 27240747)
Oral Dis. 2020 Oct;26(7):1483-1493. (PMID: 32400905)
Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1133-42. (PMID: 22403796)
Cancer Biol Ther. 2011 Apr 1;11(7):671-7. (PMID: 21307648)
Life Sci. 2019 Dec 15;239:116888. (PMID: 31639401)
Cancer Biol Ther. 2008 Jul;7(7):1139-45. (PMID: 18535404)
Microbiome. 2020 Jul 25;8(1):112. (PMID: 32711581)
Br J Pharmacol. 2014 May;171(9):2335-50. (PMID: 24428790)
J Biomed Opt. 2017 Jan 1;22(1):18003. (PMID: 28129411)
Phytother Res. 2019 Apr;33(4):1161-1172. (PMID: 30868668)
Integr Cancer Ther. 2018 Dec;17(4):1285-1296. (PMID: 30296855)
J Dent Res. 2020 Sep;99(10):1122-1130. (PMID: 32479139)
Cancer Chemother Pharmacol. 2019 May;83(5):893-904. (PMID: 30815720)
Clin Nutr. 2013 Jun;32(3):452-9. (PMID: 23102689)
Int J Cancer. 2005 Sep 1;116(3):464-70. (PMID: 15800945)
Oral Oncol. 1997 Jan;33(1):47-54. (PMID: 9192553)
Photodiagnosis Photodyn Ther. 2015 Jun;12(2):298-309. (PMID: 25612464)
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419833795. (PMID: 30879354)
J Appl Microbiol. 2018 Nov;125(5):1494-1501. (PMID: 29969527)
Cancer Res. 1981 Jun;41(6):2334-7. (PMID: 6786736)
Scand J Gastroenterol. 2020 Jan;55(1):47-54. (PMID: 31825688)
Am J Physiol Gastrointest Liver Physiol. 2011 Feb;300(2):G283-91. (PMID: 21088238)
PLoS One. 2021 Jul 26;16(7):e0253540. (PMID: 34310611)
Nutr Cancer. 1997;28(2):212-7. (PMID: 9290130)
Lasers Surg Med. 2008 Nov;40(9):625-33. (PMID: 18951429)
Exp Biol Med (Maywood). 2019 Oct;244(14):1178-1185. (PMID: 31184924)
Nutrition. 2018 Oct;54:165-172. (PMID: 29982144)
Br J Nutr. 2021 Sep 28;126(6):853-864. (PMID: 33298215)
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Apr;117(4):445-53. (PMID: 24485786)
Biomed Pharmacother. 2011 Aug;65(5):339-44. (PMID: 21723691)
Cancer Biol Ther. 2009 Sep;8(17):1623-8. (PMID: 19617702)
mBio. 2019 Mar 12;10(2):. (PMID: 30862756)
J Support Oncol. 2011 Sep-Oct;9(5):161-8. (PMID: 22024303)
J Appl Microbiol. 2021 Jun;130(6):2063-2074. (PMID: 33128836)
Drugs Aging. 2000 Oct;17(4):257-67. (PMID: 11087004)
Pharmacol Res. 2016 May;107:102-110. (PMID: 26987941)
Support Care Cancer. 2016 Jan;24(1):377-385. (PMID: 26081596)
Biochem Biophys Res Commun. 2009 Nov 27;389(4):634-9. (PMID: 19765544)
Cell Res. 2017 Jun;27(6):784-800. (PMID: 28409562)
Basic Clin Pharmacol Toxicol. 2017 Sep;121(3):159-168. (PMID: 28374966)
Biomed Pharmacother. 2019 Oct;118:109223. (PMID: 31325706)
Am J Pathol. 2004 Feb;164(2):739-46. (PMID: 14742277)
Eur J Oral Sci. 2005 Jun;113(3):210-7. (PMID: 15953245)
Cancer Biol Ther. 2008 Feb;7(2):295-302. (PMID: 18059190)
Invest New Drugs. 2014 Dec;32(6):1301-7. (PMID: 25052233)
Microbiology (Reading). 2015 Oct;161(10):1950-1960. (PMID: 26224606)
Cell Mol Gastroenterol Hepatol. 2022;13(2):441-457. (PMID: 34607083)
Anticancer Drugs. 2007 Feb;18(2):197-210. (PMID: 17159606)
J Nutr. 2007 Mar;137(3):634-40. (PMID: 17311952)
PLoS One. 2015 Sep 25;10(9):e0138746. (PMID: 26406888)
Oral Oncol. 1999 Mar;35(2):197-202. (PMID: 10435156)
Mucosal Immunol. 2014 Sep;7(5):1079-93. (PMID: 24424522)
Biomed Pharmacother. 2021 Feb;134:111152. (PMID: 33373916)
Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1017-1025. (PMID: 28590519)
Int J Mol Sci. 2020 Jan 08;21(2):. (PMID: 31936237)
BMC Complement Altern Med. 2016 Mar 10;16:99. (PMID: 26965456)
Pharmaceutics. 2021 Jul 04;13(7):. (PMID: 34371713)
BMC Cancer. 2021 Dec 18;21(1):1343. (PMID: 34922485)
Benef Microbes. 2016 Sep;7(4):549-57. (PMID: 27133563)
J Pharm Pharmacol. 2001 Oct;53(10):1373-8. (PMID: 11697545)
Cancer Res. 1994 Mar 1;54(5):1135-8. (PMID: 8118793)
Mol Cancer. 2014 Feb 05;13:23. (PMID: 24495286)
Environ Sci Pollut Res Int. 2017 Nov;24(31):24447-24453. (PMID: 28895047)
Clin Exp Immunol. 2010 Nov;162(2):298-305. (PMID: 20731673)
J Immunol Res. 2021 Sep 14;2021:9321196. (PMID: 34568500)
Mol Cancer Ther. 2016 Jun;15(6):1376-86. (PMID: 27197307)
PLoS One. 2014 Dec 05;9(12):e113378. (PMID: 25478918)
PLoS One. 2015 Aug 12;10(8):e0135102. (PMID: 26266941)
Scand J Gastroenterol. 2013 Aug;48(8):959-68. (PMID: 23865592)
Phytother Res. 2017 Feb;31(2):312-320. (PMID: 27910140)
J Surg Res. 2004 Sep;121(1):84-91. (PMID: 15313380)
Cancer Chemother Pharmacol. 2021 Mar;87(3):327-336. (PMID: 33130913)
J Med Invest. 2014;61(1-2):59-64. (PMID: 24705750)
Pediatr Surg Int. 2008 Dec;24(12):1303-11. (PMID: 18956197)
Phytother Res. 2019 Jan;33(1):90-106. (PMID: 30281176)
Nutr Cancer. 2021;73(3):523-533. (PMID: 32367766)
Lipids. 2012 Jul;47(7):669-78. (PMID: 22648862)
PLoS One. 2015 Jan 07;10(1):e0116213. (PMID: 25565296)
Carbohydr Polym. 2021 Mar 15;256:117545. (PMID: 33483054)
Oral Oncol. 2002 Jul;38(5):478-85. (PMID: 12110343)
Br J Pharmacol. 2020 May;177(10):2393-2408. (PMID: 31976547)
FASEB J. 2006 Aug;20(10):1709-11. (PMID: 16809434)
Dig Dis Sci. 2004 Mar;49(3):425-33. (PMID: 15139492)
Appl Microbiol Biotechnol. 2021 Jan;105(1):327-340. (PMID: 33205285)
Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):261-6. (PMID: 7492924)
J Am Assoc Lab Anim Sci. 2020 May 1;59(3):343. (PMID: 32156325)
Br J Pharmacol. 2021 Oct;178(20):4193-4209. (PMID: 34216140)
Nutr Cancer. 2015;67(2):364-71. (PMID: 25587665)
J Pediatr Gastroenterol Nutr. 2006 Jan;42(1):53-8. (PMID: 16385254)
J Integr Med. 2021 Mar;19(2):144-157. (PMID: 33353843)
J Pharm Pharmacol. 2009 Jun;61(6):795-800. (PMID: 19505371)
Pediatr Neonatol. 2019 Jun;60(3):252-260. (PMID: 30150027)
Biol Pharm Bull. 2013;36(10):1528-34. (PMID: 24088251)
Drug Chem Toxicol. 2015 Oct;38(4):442-51. (PMID: 25609004)
Exp Biol Med (Maywood). 2013 Nov 1;238(11):1305-17. (PMID: 24047797)
Nutr Cancer. 2016 Oct;68(7):1171-80. (PMID: 27618153)
Cancer. 2004 May 1;100(9 Suppl):2026-46. (PMID: 15108223)
Cancer Biol Ther. 2011 Sep 1;12(5):399-406. (PMID: 21705855)
Int J Mol Sci. 2019 Jan 10;20(2):. (PMID: 30634582)
Int J Mol Sci. 2018 Sep 29;19(10):. (PMID: 30274314)
Dig Dis Sci. 2004 Jan;49(1):65-72. (PMID: 14992437)
Eur Arch Otorhinolaryngol. 2007 Feb;264(2):197-203. (PMID: 17063354)
Nature. 2021 Aug;596(7871):262-267. (PMID: 34349263)
J Pharmacol Sci. 2020 May;143(1):30-38. (PMID: 32151540)
Cancer Biol Ther. 2009 Mar 15;8(6):505-11. (PMID: 19305160)
BMC Immunol. 2022 Apr 21;23(1):19. (PMID: 35448938)
PLoS One. 2013 Dec 20;8(12):e82834. (PMID: 24376587)
J Ethnopharmacol. 2016 May 13;183:143-150. (PMID: 26934449)
PLoS One. 2016 Jul 27;11(7):e0158851. (PMID: 27463799)
J Cancer Res Clin Oncol. 2015 Jun;141(6):983-92. (PMID: 25398650)
Support Care Cancer. 2021 May;29(5):2415-2421. (PMID: 32918133)
Clin Cancer Res. 2007 Apr 15;13(8):2449-54. (PMID: 17438104)
Int J Oncol. 2019 Apr;54(4):1376-1386. (PMID: 30968152)
Arch Oral Biol. 2019 May;101:51-56. (PMID: 30889505)
Scand J Gastroenterol. 2008 Jan;43(1):59-65. (PMID: 18938749)
Cancer Biol Ther. 2009 Sep;8(17):1662-7. (PMID: 19633421)
Basic Clin Pharmacol Toxicol. 2017 Dec;121(6):480-486. (PMID: 28667794)
Pathol Oncol Res. 2020 Apr;26(2):955-965. (PMID: 30919275)
Cancer Chemother Pharmacol. 2011 Jun;67(6):1445-53. (PMID: 20814790)
Science. 2005 Aug 19;309(5738):1256-9. (PMID: 16109882)
Transl Oncol. 2017 Aug;10(4):612-620. (PMID: 28666190)
Cancer Biol Ther. 2014 Aug;15(8):982-91. (PMID: 24800927)
BMC Cancer. 2019 Oct 29;19(1):1016. (PMID: 31664952)
Clin Exp Immunol. 2017 Apr;188(1):36-44. (PMID: 28052346)
Exp Anim. 2020 Apr 24;69(2):144-152. (PMID: 31787709)
Life Sci. 2022 Jan 15;289:120243. (PMID: 34922941)
Oral Surg Oral Med Oral Pathol. 1990 Apr;69(4):437-43. (PMID: 2326035)
JPEN J Parenter Enteral Nutr. 2010 Sep-Oct;34(5):530-7. (PMID: 20852181)
Biomed Pharmacother. 2018 Oct;106:910-916. (PMID: 30119262)
Gut Microbes. 2016 Sep 2;7(5):414-23. (PMID: 27459363)
Colloids Surf B Biointerfaces. 2018 Jul 1;167:468-473. (PMID: 29723818)
Eur J Pharmacol. 2022 Mar 15;919:174810. (PMID: 35151644)
PLoS Pathog. 2019 Apr 22;15(4):e1007717. (PMID: 31009520)
Surg Infect (Larchmt). 2014 Feb;15(1):50-7. (PMID: 24180344)
Sci Rep. 2018 May 29;8(1):8193. (PMID: 29844396)
Cancer Chemother Pharmacol. 1993;31(5):376-80. (PMID: 8431971)
Nutrients. 2021 Mar 10;13(3):. (PMID: 33801889)
Support Care Cancer. 2020 Feb;28(2):867-876. (PMID: 31165336)
Cancer Chemother Pharmacol. 2012 Jul;70(1):39-48. (PMID: 22729158)
J Gastroenterol Hepatol. 2020 May;35(5):806-814. (PMID: 31674687)
BMC Gastroenterol. 2012 Jul 13;12:35. (PMID: 22524518)
Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1;311(2):G324-33. (PMID: 27445347)
Life Sci. 2020 Jul 1;252:117612. (PMID: 32247004)
Sci Rep. 2021 Dec 1;11(1):23241. (PMID: 34853351)
Phytomedicine. 2022 Jul;101:154092. (PMID: 35430483)
J Microbiol Biotechnol. 2022 Apr 28;32(4):405-418. (PMID: 35283422)
Food Funct. 2018 May 23;9(5):2695-2704. (PMID: 29756138)
Int J Mol Sci. 2017 Jan 27;18(2):. (PMID: 28134832)
PLoS One. 2014 Nov 06;9(11):e110675. (PMID: 25375224)
Br J Pharmacol. 2013 Mar;168(6):1388-400. (PMID: 23072534)
Food Funct. 2015 Feb;6(2):415-22. (PMID: 25407449)
Chemotherapy. 2011;57(1):43-53. (PMID: 21282945)
Microb Cell Fact. 2017 Feb 13;16(1):27. (PMID: 28193209)
Neurogastroenterol Motil. 2017 Mar;29(3):. (PMID: 27686064)
Front Microbiol. 2018 May 15;9:983. (PMID: 29867884)
J Negat Results Biomed. 2014 Apr 11;13:6. (PMID: 24721659)
Int J Surg. 2021 Apr;88:105906. (PMID: 33789826)
Am J Pathol. 2014 Jul;184(7):2023-34. (PMID: 24952429)
Int J Cancer. 2003 Nov 1;107(2):303-8. (PMID: 12949812)
Pediatr Surg Int. 2011 Feb;27(2):151-8. (PMID: 21080177)
Eur J Pharm Sci. 2022 Jun 1;173:106182. (PMID: 35405270)
PLoS One. 2014 Jan 21;9(1):e85184. (PMID: 24465501)
Molecules. 2020 Jun 17;25(12):. (PMID: 32560278)
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):981-90. (PMID: 22797601)
Cancer Chemother Pharmacol. 2009 Jan;63(2):239-51. (PMID: 18351341)
Probiotics Antimicrob Proteins. 2022 Jun;14(3):486-500. (PMID: 34255281)
J Neurosci Res. 2022 Jan;100(1):237-250. (PMID: 34510524)
Fitoterapia. 2019 Jul;136:104161. (PMID: 31048010)
Eur J Pharmacol. 2006 Dec 3;551(1-3):152-5. (PMID: 17046745)
Sci Rep. 2020 Jan 17;10(1):625. (PMID: 31953420)
Head Neck. 2018 Mar;40(3):577-583. (PMID: 29155481)
Oral Surg Oral Med Oral Pathol. 1992 Dec;74(6):749-55. (PMID: 1488231)
Cancer Res. 1996 May 1;56(9):2082-5. (PMID: 8616854)
Nutr Cancer. 2015;67(3):486-93. (PMID: 25803482)
Cell Death Dis. 2019 Sep 26;10(10):714. (PMID: 31558709)
Biol Pharm Bull. 2019;42(10):1733-1740. (PMID: 31582661)
Cancer Chemother Pharmacol. 2010 Apr;65(5):913-21. (PMID: 19690860)
Toxicol Mech Methods. 2018 May;28(4):262-267. (PMID: 29117755)
Br J Nutr. 2010 Aug;104(4):513-9. (PMID: 20377926)
Cancer Biol Ther. 2011 Jul 15;12(2):131-8. (PMID: 21508671)
Cancer Lett. 2002 Dec 10;187(1-2):153-62. (PMID: 12359363)
J Cell Physiol. 2007 Jan;210(1):144-52. (PMID: 16998802)
Pharmacol Res. 2014 Apr;82:21-33. (PMID: 24681512)
Support Care Cancer. 2019 Jun;27(6):2313-2320. (PMID: 30350190)
Cancer Res. 2001 Jan 15;61(2):687-93. (PMID: 11212269)
J Complement Integr Med. 2016 Dec 1;13(4):377-385. (PMID: 27682716)
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19143-8. (PMID: 24191041)
Cancer Biol Ther. 2006 Sep;5(9):1189-95. (PMID: 16931906)
Cancer. 2004 May 1;100(9 Suppl):1995-2025. (PMID: 15108222)
Gut. 2013 Dec;62(12):1724-33. (PMID: 23086829)
Amino Acids. 2021 Sep;53(9):1415-1430. (PMID: 34410507)
Phytother Res. 2019 Apr;33(4):881-890. (PMID: 30672024)
Sci Rep. 2021 Jul 19;11(1):14687. (PMID: 34282203) - Contributed Indexing: Keywords: 5-fluorouracil; animal models; chemotherapy; gastrointestinal mucositis; intraperitoneal; intravenous; irinotecan; methotrexate; mucositis; oral mucositis; platinum-based drugs
- Accession Number: 7673326042 (Irinotecan)
U3P01618RT (Fluorouracil)
0 (Antineoplastic Agents)
YL5FZ2Y5U1 (Methotrexate) - Publication Date: Date Created: 20221211 Date Completed: 20221216 Latest Revision: 20240908
- Publication Date: 20240909
- Accession Number: PMC9737148
- Accession Number: 10.3390/ijms232315434
- Accession Number: 36499758
- Source:
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.